Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Labyrinth Biopharma is a specialized Contract Development and Manufacturing Organization (CDMO) and Contract Research Organization (CRO) based in West Lafayette, Indiana. The company provides end-to-end services for the pharmaceutical and biotechnology sectors, with a core focus on formulation development and lyophilization (freeze-drying) cycle optimization. Labyrinth Biopharma operates advanced facilities designed for aseptic fill-finish operations, supporting the production of clinical trial materials for Phase 1 and Phase 2 studies. Their technical expertise encompasses a variety of product types, including small molecules, recombinant proteins, monoclonal antibodies, and vaccines. By integrating analytical testing with manufacturing capabilities, the company assists clients in transitioning drug candidates from the laboratory to clinical applications. Labyrinth Biopharma is recognized for its lab-to-clinic philosophy, emphasizing speed and quality in drug product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Labyrinth Biopharma.